Catalano Glenn, Houston Sally H, Catalano Maria C, Butera Adam S, Jennings Shannon M, Hakala Sheryl M, Burrows Stephanie L, Hickey Mark G, Duss Charles V, Skelton David N, Laliotis Georgia J
Department of Psychiatry and Behavioral Medicine, and College of Medicine, University of South Florida, Tampa, FL, USA.
South Med J. 2003 Feb;96(2):141-5. doi: 10.1097/01.SMJ.0000050683.36014.2E.
Previous studies have reported an increase in psychiatric symptoms in seriously ill patients who were placed in resistant organism isolation. We conducted this study to assess whether there is an increase in symptoms of anxiety and depression in patients who are not critically ill and are placed in isolation.
Patients hospitalized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus species infections were evaluated with the Hamilton Anxiety Rating Scale and the Hamilton Depression Rating Scale at baseline and again during hospitalization. The results were then compared with the results of patients who were hospitalized for infectious diseases that did not require isolation.
Patients in isolation had significantly higher scores on both the anxiety and depression scales at the time of follow-up than did patients who were not isolated. There was no significant difference between the scores of the two groups before isolation.
The results of this preliminary study suggest that placement in resistant organism isolation may increase hospitalized patients' levels of anxiety and depression.
既往研究报道,被安置于耐菌隔离环境中的重症患者精神症状会增加。我们开展本研究以评估未患重症且被安置于隔离环境中的患者焦虑和抑郁症状是否会增加。
对因耐甲氧西林金黄色葡萄球菌或耐万古霉素肠球菌感染而住院的患者,在基线时以及住院期间再次使用汉密尔顿焦虑量表和汉密尔顿抑郁量表进行评估。然后将结果与因不需要隔离的传染病而住院的患者的结果进行比较。
随访时,隔离患者在焦虑量表和抑郁量表上的得分均显著高于未隔离患者。隔离前两组患者的得分无显著差异。
这项初步研究的结果表明,安置于耐菌隔离环境中可能会增加住院患者的焦虑和抑郁水平。